Mav
No doubt management sweeteners in this kind of transaction, on the other hand Neal becomes accountable to the chinese. Nothing comes for free.
What i like about the deal is the offer will essentially leave only the true believers left holding as shareholders. Those with any doubts will bale at a reasonable price. Therefore you will have those that want to hold and those that an to buy = more buyers than sellers
People are screaming blue murder 55 is so cheap .... its been stolen. Well if thats the view why werent those some people buying up when it was trading at sub 40 last Monday or in the mid 30s two months ago??????
I have printed the 101 page document and will read the detail. However I reiterate I am focusing on the company going forward. Its forward production profile will create lots of cash to grow. I am also focusing on does the stock become more or less attractive going forward to insto investors. My answer at this stage is more, much more
you talk about dilution, I wonder what investec would have demanded in temms of options for the 210 million dollar loan. You tlak about dilution, I wonder what cash flow savings, risk mitigation, capital flexibility not having a big lan creates. Happy to hear the negatives in the form of a discussion of pro and con for each point
Hey Gus444 I hope Neal isnt on spending too mucn time on HC at 700 am SA time answering your posts an is preparing for the media conference instead - you guys are classics. He needs Jim Carey and Aam Sandler when you guys are on
- Forums
- ASX - By Stock
- GDO
- genius
genius, page-11
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GDO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online